Trial Profile
A study evaluating safety, efficacy and effect of dose reduction of etanercept in patients with psoriasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Aug 2017 New trial record
- 03 Aug 2017 Results of pooled analysis of 10 trials (NCT00245960, NCT00111449, NCT00663052, NCT00454584) generating evidence concerning the number of patients dropping out of etanercept trials published in the British Journal of Dermatology
- 22 Jun 2005 Results published in the British Journal of Dermatology